What is the primary driver of the significant increase in net sales for the reported period?

The primary driver of the significant increase in net sales for the thirteen weeks ended July 2, 2005, is the acquisition of Eckerd's retail drugstores and pharmacy benefit management businesses, which closed on July 31, 2004. This acquisition contributed substantially to the reported revenue growth.

How did the Eckerd acquisition impact operating expenses?

The acquisition of the Eckerd businesses led to an increase in operating expenses as a percentage of net sales. This was primarily due to the integration of the acquired stores, which incurred higher labor costs, and the fact that the acquired stores generally have lower average sales per store compared to existing CVS stores.

What is the company's outlook on liquidity and its ability to fund operations?

CVS anticipates that cash flows from operations, supplemented by commercial paper and long-term borrowings, will be sufficient to fund business growth, working capital needs, capital expenditures, and debt service requirements. The company has a solid liquidity position with ample cash on hand and access to credit facilities, and maintains investment-grade debt ratings.

Are there any significant legal proceedings that investors should be aware of?

Yes, CVS is involved in several legal proceedings, including consolidated securities litigation, an ERISA action, and a shareholder derivative suit, all stemming from allegations related to past stock performance. The company has entered into settlement agreements that have been preliminarily approved by the court and are primarily covered by insurance. Additionally, investigations by Rhode Island state and federal authorities into business relationships with former state officials are ongoing, and CVS is cooperating fully.

CVS 10-Q Quarterly Report Q3 FY2005 — Revenue, Net Income, EPS

Summary

CVS Corporation's Q2 2005 filing shows robust top-line growth, driven significantly by the acquisition of Eckerd's assets in July 2004. Net sales for the thirteen weeks ended July 2, 2005, reached $9.1 billion, a substantial increase from $6.9 billion in the prior year period, reflecting a 31.4% growth rate. This growth was fueled by both the integration of acquired stores and continued same-store sales increases in pharmacy and front-store categories. The company's operating profit also saw a healthy increase, rising to $477.7 million from $387.2 million year-over-year. Despite the strong revenue performance, investors should note the increase in operating expenses, which grew at a faster pace than sales, partly due to the integration of acquired stores and higher labor costs. Net earnings available to common shareholders also increased, reaching $272.4 million ($0.33 per diluted share) compared to $230.8 million ($0.28 per diluted share) in the prior year. The company also highlighted its ongoing capital expenditures for store development and remodeling, as well as its solid liquidity position supported by operating cash flows and available credit facilities.

Key Highlights

1Net sales for the thirteen weeks ended July 2, 2005, increased by 31.4% to $9.1 billion, largely due to the Eckerd acquisition.
2Operating profit grew by 23.4% to $477.7 million for the thirteen-week period compared to the prior year.
3Net earnings available to common shareholders increased to $272.4 million, or $0.33 per diluted share, up from $230.8 million, or $0.28 per diluted share, in the same period last year.
4The company made significant additions to property and equipment ($731.7 million in the first six months of 2005), primarily for store development and remodeling.
5Operating expenses as a percentage of net sales increased due to the integration of acquired stores and higher labor costs.
6The company maintained a strong liquidity position, with $414.1 million in cash and cash equivalents and access to substantial credit facilities.
7CVS has two primary business segments: Retail Pharmacy and Pharmacy Benefit Management (PBM), with the Retail segment accounting for the vast majority of sales and operating profit.

CVS HEALTH Corp Quarterly Report for Q3 Ended Jul 2, 2005

Summary

Key Highlights

Frequently Asked Questions